This report describes the global market size of Medical Cannabis from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027.
For the geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report includes global key players of Medical Cannabis as well as some small players.
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Types Segment:
- Dronabinol
- Nabilone
- Cannabidiol
- Cannabinol
Scope
- Base Year: 2022
- Historical Data: from 2017 to 2021
- Forecast Data: from 2022 to 2027
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Medical Cannabis Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Medical Cannabis by Region
8.2 Import of Medical Cannabis by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Medical Cannabis Market in North America (2017-2027)
9.1 Medical Cannabis Market Size
9.2 Medical Cannabis Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Medical Cannabis Market in South America (2017-2027)
10.1 Medical Cannabis Market Size
10.2 Medical Cannabis Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Medical Cannabis Market in Asia & Pacific (2017-2027)
11.1 Medical Cannabis Market Size
11.2 Medical Cannabis Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southeast Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Medical Cannabis Market in Europe (2017-2027)
12.1 Medical Cannabis Market Size
12.2 Medical Cannabis Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Medical Cannabis Market in MEA (2017-2027)
13.1 Medical Cannabis Market Size
13.2 Medical Cannabis Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Medical Cannabis Market (2017-2022)
14.1 Medical Cannabis Market Size
14.2 Medical Cannabis Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Medical Cannabis Market Forecast (2022-2027)
15.1 Medical Cannabis Market Size Forecast
15.2 Medical Cannabis Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
- GW Pharmaceuticals plc
- Medigrow
- Akanda Corp.
- Spectrum Cannabis
- Bedrocan
- Verve Dynamic
- TerraTech Corp.
- Cannabis Science Inc.
- Peak Pharmaceuticals Inc.
- Cannabis-Rx Inc
- Nemus Biosciences Inc.
- Gb Sciences
- Insys Therapeutics
- Alkem Laboratories
- Akorn
- Ascent Pharmaceuticals
- TEVA
- Greenwich Biosciences
- Cronos Group
- Aurora Cannabis
- Aphria
- Tilray
- Constellation Brands
- MedBox Inc.
- TerraTech Corp.
- Cannabis Science Inc.
- Phoenix Life Sciences International Limited.
- MGC Pharma
For more information about this report visit https://www.researchandmarkets.com/r/hxys1t
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900